And, Medicare has announced for people with obesity or overweight at risk for a recurrent myocardial event, they are going to now allow coverage for medications which lower heart risk, which at this time, only includes Wegovy
Cancer Risk A review and discussion stated: ROS production is significantly increased in cancer cells because of mitochondrial dysfunction, altered metabolism, and frequent genetic mutations, resulting in an accumulation of large amounts of oxidized protein, DNA, and lipids as an adaptive response, cancer cells harbor elevated levels of ROS-scavenging molecules
withdraw the needle slightly and reposition for subcutaneous delivery
Fller M, Feil S, Ghoreschi K, Koka S, Gerling A, Thunemann M, et al